Anti-MRC2 antibody
| Name | Anti-MRC2 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab70132 |
| Prices | $401.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | FC WB ELISA IHC-P ICC/IF ICC/IF |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic peptide derived from an internal sequence of human MRC2 |
| Description | Rabbit Polyclonal |
| Gene | MRC2 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab70132, at a 1/500 dilution, staining MRC2 in HepG2 cells by Immunofluorescence, in the absence or presence of the immunising peptide.
ab70132, at a 1/50 dilution, staining MRC2 in paraffin embedded human brain tissue by Immunohistochemistry, in the absence or presence of the immunising peptide.
All lanes : Anti-MRC2 antibody (ab70132) at 1/500 dilutionLane 1 : 293 cell extractsLane 2 : 293 cell extracts with immunising peptide at 5 µgLysates/proteins at 5 µg per lane.
ab70132 staining IMRC2 in tonsillar tissue by Flow Cytometry. Gating strategy : Viable leukocytes gated in FSC/SSC. The sample was incubated with the primary antibody (dilution 1/5 in PBS/0.5%BSA/2.5mM EDTA), for 30 minutes at 4°C. An FITC-conjugated goat polyclonal to Rabbit IgG (dilution 1/50) was used as secondary antibody.See Abreview
ab70132 staining MRC2 in Human pancreatic cancer tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with Inhibitor CM for 4 minutes at 37°C; antigen retrieval was by heat mediation in Tris/Borate/EDTA buffer pH 8. Samples were incubated with primary antibody (1/50 ) for 32 minutes at 37°C. An undiluted HRP-conjugated Goat anti-rabbit IgG polyclonal was used as the secondary antibody.See Abreview
Product References
Pancreatic cancer cells enhance the ability of collagen internalization during - Pancreatic cancer cells enhance the ability of collagen internalization during
Ikenaga N, Ohuchida K, Mizumoto K, Akagawa S, Fujiwara K, Eguchi D, Kozono S, Ohtsuka T, Takahata S, Tanaka M. PLoS One. 2012;7(7):e40434.
Glycogene expression alterations associated with pancreatic cancer - Glycogene expression alterations associated with pancreatic cancer
Maupin KA, Sinha A, Eugster E, Miller J, Ross J, Paulino V, Keshamouni VG, Tran N, Berens M, Webb C, Haab BB. PLoS One. 2010 Sep 27;5(9):e13002.